window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : January 24, 2026

  • News
  • About Us
Contact Us

Precision Medicine

  • Artificial Intelligence,Biotech,Drug Development,Pharmaceuticals and therapeutics,Precision medicine,Research & Development,Technology and platforms

    CytoReason unveils LINA, AI agent accelerated by NVIDIA for pharma R&D

    CytoReason has unveiled LINA, an AI agent designed to support [...]

    January 13, 2026
  • Biotech,Cell & Gene Therapy,Genetic Diseases,Genomics and sequencing,Rare Diseases,Research & Development,Technology and platforms

    PacBio HiFi adopted to study sudden unexplained death in childhood and advance precision therapies for rare diseases

    PacBio is supporting two research initiatives that use its HiFi [...]

    January 13, 2026
  • Clinical Trials,Immunology,Neurosciences,Precision medicine

    AC Immune interim Phase 2 data suggest ACI-7104.056 may slow Parkinson’s disease progression

      AC Immune SA has reported positive interim results from [...]

    December 11, 2025
  • Clinical Trials,Oncology,Research & Development

    €1 million investment for BiPER Therapeutics to launch BPR001-615 BiP inhibitor trial

    BiPER Therapeutics has raised €1 million ($1.16M) to support the [...]

    December 2, 2025
  • Artificial Intelligence,Genomics and sequencing,Research & Development

    Sheba, Mount Sinai and NVIDIA launch AI collaboration to decode unexplored regions of the human genome

    ARC Innovation at Sheba Medical Center and the Icahn School [...]

    November 18, 2025
  • Oncology,Pharmaceuticals and therapeutics,Research & Development

    UK nuclear materials to power new precision cancer therapies

    The UK is launching a major programme to convert used [...]

    November 18, 2025
  • Cell & Gene Therapy,Clinical Development,Partnerships & Funding,Pharmaceuticals and therapeutics,Research & Development

    CTMC and Einstein Hospital Israelita launch global cell therapy alliance

    CTMC, a joint venture between Resilience and MD Anderson Cancer [...]

    October 2, 2025
  • Cell & Gene Therapy,Pharmaceuticals and therapeutics,Research & Development,RNA Therapeutics,Technology and platforms

    N4 Pharma advances targeted RNA delivery with SRI collaboration

    N4 Pharma plc, the UK biotech developing its proprietary Nuvec® [...]

    September 23, 2025
  • Clinical Development,Clinical Trials,Pharmaceuticals and therapeutics,Precision medicine,Rare Diseases

    A potential first-in-class treatment for children with achondroplasia is now in clinical testing

    Tyra Biosciences has dosed the first child in BEACH301, its [...]

    August 22, 2025
  • Chronic diseases,Genomics and sequencing,Precision medicine,Research & Development

    Genomics and sequencing: Sapient study uses rLC-MS to map metabolic aging and disease insights in 26,000 samples

    Sapient has published a large-scale metabolomics study using its rapid [...]

    August 20, 2025
12Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • MaaT Pharma randomizes first patient in IMMUNOLIFE Phase 2 NSCLC microbiome study
    Categories: Uncategorised
  • Datwyler, LTS Device Technologies, and Stevanato Group collaborate on large-volume self-administration solutions
    Categories: Biologics & Biosimilars, Drug Delivery & Formulation, Medical devices, Patient Centricity, Pharmaceuticals and therapeutics
  • NeuroVice seizure oral injury device now available through BlinkRx
    Categories: Central Nervous System, Digital Health, Medical devices, Patient Centricity, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top